title: International Conference on Translational Research ICTR 2003 Conference Summary: marshalling resources in a complex time.
abstract: The knowledge, tools, and environment for the practice of radiation oncology are changing rapidly. The National Cancer Institute has articulated the need for a balanced portfolio, including the interrelated components of discovery, development, and delivery. Underpinning practice is the emerging knowledge from molecular, cellular, and tumor biology that is the engine of discovery. The use of high-throughput technologies to analyze biochemical and molecular profiles will ultimately enable the individualization of cancer treatment requiring the appropriate integration of radiation with a range of systemic therapies, including chemotherapy, biologic therapy, and immunotherapy. Technological advances in treatment delivery using photons, brachytherapy, particle therapy, radioisotopes, and other forms of energy require an improved ability to localize the tumor and critical subregions and to ensure necessary tissue immobilization and/or real-time target adjustment. Functional imaging is helping to define tumor characteristics and response to treatment. The development of appropriate radiation oncology treatment requires a wide range of expertise, a multimodality approach, and multi-institutional collaboration to provide improved and cost-effective outcome. The delivery of appropriate cancer care to those who need it requires biology and technology but also reaching the underserved populations worldwide. ICTR 2003 demonstrated substantial progress in translational radiation oncology. Faced with financial constraints for research and patient care, the broad field of radiation oncology must continually examine and balance its research and development portfolio and invest in its future leaders to enable it be an important contributor to the future of cancer care.
authors.affiliation: Radiation Oncology Sciences Program, Center for Cancer Research, Division of Cancer Treatment and Diagnosis, National Cancer Institute/NIH, Bldg. 10, B3-B69, Bethesda, MD 20892-1002, USA. ccoleman@mail.nih.gov
authors.forename: C Norman
authors.initials: CN
authors.lastname: Coleman
mesh_terms: D001695:Biology; D035843:Biomedical Research / Q000639:trends; D006801:Humans; D008954:Models, Biological; D009369:Neoplasms / Q000532:radiotherapy*; D018787:Radiation Oncology / Q000379:methods / Q000639:trends*; D013557:Switzerland; D013679:Technology, Radiologic / Q000379:methods / Q000639:trends*